Otrivin Comp (Xylometazoline Hydrochloride, Ipratropium Bromide)

Xylometazoline hydrochloride, the active ingredient in Otrivin Comp, is a nasal decongestant presented as a combination formulation for topical nasal use. It relieves nasal congestion associated with colds, sinusitis and allergic rhinitis in adults and children. GNH USA supplies Otrivin Comp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otrivin Comp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivin Comp combines a nasal decongestant and an anticholinergic to address upper‑respiratory tract congestion.

- Common cold: reduces nasal blockage and improves airflow. - Acute sinusitis: alleviates sinus pressure and nasal obstruction. - Allergic rhinitis: diminishes watery discharge and nasal stuffiness. - Nasal surgery recovery: helps maintain clear nasal passages post‑operatively.

Adverse reactions may occur following intranasal administration of Otrivin Comp.

Common Side Effects: - Nasal burning or stinging sensation. - Mild headache. - Transient nasal dryness. - Sneezing. - Bitter taste. - Mild epistaxis.

Serious or Rare Side Effects: - Severe nasal irritation or ulceration. - Persistent hypertension. - Allergic reactions such as rash, itching or angio‑angio‑edema. - Significant nosebleeds. - Vision changes. - Anaphylaxis.

Before using Otrivin Comp, consider the following safety measures:

- Contraindication: Do not use if any ​       ​  ​  ​ ​ ​  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​ - Age restriction: Use  \\  \\ \\

Otriving   """"  """ """ " "" "" ""  " " """  "" 

t  t